4
Changes in Ownership
Aldeyra Therapeutics, Inc. Filed Acc 0000950170-23-047530
President and CEO gave up 73,807 shares (to pay taxes)
- President and CEO acquired 273,058 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Brady Todd C President and CEO | 2023-09-07 | Option exercise | +192,084 | $0.55 | $106,030 | 1,647,369 | D |
| Brady Todd C President and CEO | 2023-09-07 | Option exercise | +32,953 | $0.55 | $18,190 | 1,680,322 | D |
| Brady Todd C President and CEO | 2023-09-07 | Option exercise | +48,021 | $0.55 | $26,508 | 1,728,343 | D |
| Brady Todd C President and CEO | 2023-09-07 | Shares withheld for taxes | −73,807 | $7.22 | $532,887 | 1,654,536 | D |
| Derivatives | |||||||
| Brady Todd C President and CEO | 2023-09-07 | Option exercise · Stock Option (right to buy) | −192,084 | 0 | D | ||
| Brady Todd C President and CEO | 2023-09-07 | Option exercise · Stock Option (right to buy) | −32,953 | 0 | D | ||
| Brady Todd C President and CEO | 2023-09-07 | Option exercise · Stock Option (right to buy) | −48,021 | 0 | D | ||
Loading xslF345X05/ownership.xml…